Skip to content

Testing a new aphasia therapy for words and conversation delivered in the virtual world, EVA Park

A feasibility randomised controlled trial of Virtual, Elaborated Semantic Feature Analysis (VESFA)

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ISRCTN
Registry ID
ISRCTN15880384
Enrollment
36
Registered
2025-10-16
Start date
2020-10-05
Completion date
Unknown
Last updated
2026-02-09

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Communication intervention for patients with aphasia Nervous System Diseases

Interventions

The VESFA trial was a single-blind, phase II feasibility randomised controlled trial comparing usual care plus the VESFA intervention (VESFA+UC) with a usual care control (UCC). Participants were rand

Sponsors

City St George's, University of London
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 100 Years

Inclusion criteria

Inclusion criteria: 1. Diagnosis of stroke 2. At least four months post-stroke 3. Aged 18 years or older 4. Presence of word-finding difficulties due to post-stroke aphasia 5. Score of less than 76/100 on the naming and word finding subtests of the Western Aphasia Battery (Kertesz, 2007) 6. Score of 6/10 or above on the Frenchay Aphasia Screening Test (Enderby et al., 1987) 7. Sufficient comprehension to: - Understand the participant information sheet - Complete outcome measures such as the SAQOL-39g - Follow instructions in a virtual environment without face-to-face support 8. Availability of a person (living in the same household or COVID bubble) to assist with technical issues 9. Access to a computer meeting the minimum system requirements for Second Life or willingness to borrow a laptop from the University 10. Willingness to grant remote access to their computer via Zoom remote control or TeamViewer for technical support

Exclusion criteria

Exclusion criteria: 1. Diagnosis of a condition affecting cognition other than stroke (e.g., dementia) 2. Severe uncorrected visual problems that would prevent access to computer-based stimuli 3. Severe uncorrected hearing problems that would prevent access to computer-based stimuli 4. Presence of a severe or potentially terminal co-morbidity 5. Not being a fluent English speaker prior to stroke (based on self or family report)

Design outcomes

Primary

MeasureTime frame
1. Feasibility of delivering the intervention remotely is measured using participant questionnaires and session cancellation rates due to technical difficulties at post-intervention 2. Feasibility of recruitment is measured using screening logs and consent rates at baseline 3. Feasibility of retention is measured using participant availability data at follow-up 4. Acceptability of research processes is measured using dropout rates and proportion of missing data per outcome measure across baseline, mid-point and follow-up 5. Acceptability of research processes is further measured using post-therapy and usual care questionnaires administered at post-intervention 6. Acceptability of intervention to participants is measured using adherence rates recorded during the intervention period and post-therapy questionnaire responses at post-intervention

Secondary

MeasureTime frame
1. Treated word retrieval is measured using the VESFA Naming Test at T1, T2 and T3 2. Independent word retrieval is measured using the Boston Naming Test at T1, T2 and T3 3. Functional communication is measured using the Scenario Test, UK at T1, T2 and T3 4. Word production in discourse is measured using the Nicholas and Brookshire protocol at T1, T2 and T3 5. Health-related quality of life is measured using the Stroke and Aphasia Quality of Life questionnaire-39 item, general (SAQOL-39g) at T1, T2 and T3 6. Mood is measured using the General Health Questionnaire-12 item (GHQ-12) at T1, T2 and T3 7. Aphasia severity is measured using the Western Aphasia Battery – Revised (WAB-R) at T1, T2 and T3

Countries

England, United Kingdom

Contacts

Public ContactNiamh Devane
niamh.devane.2@city.ac.uk+44 2070408821

Outcome results

None listed

Source: ISRCTN (via WHO ICTRP) · Data processed: Feb 15, 2026